Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR PlatformContributed by: Business WireLogoTagsResearchMedical DevicesGeneticsClinical TrialsHealth TechnologyOther HealthBiotechnologyPharmaceuticalHealthScienceRenMab RenMice Japan Patent Office